Faced with an increasing CLABSI rate on their oncology unit, nurse leaders at this rural Northwest hospital surveyed their staff to identify the changes they needed to make. Implementing those changes resulted in a dramatic improvement in patient care outcomes.
In this study the records of 5,216 cancer survivors and 19,588 non-cancer controls were reviewed for patterns of prescription medication use and polypharmacy.
Results of a cross-over trial presented at the NACNS 2018 Annual Conference demonstrate the efficacy of antiseptic device swabs in reducing central line-associated bloodstream infections in oncology patients with central venous catheters.
CNS-led team of investigators sought to determine if air-assisted technology could reduce patient, as well as nurse, injuries incurred when repositioning patients. Results were presented at the NACNS 2018 Annual Conference.
Compared with placebo, gabapentin administered pre- and postoperatively may reduce the time to postoperative opioid cessation, but was not shown to improve postoperative pain resolution.
Researchers sought to determine the link between opioid use among patients with advanced cancer and health care use such as urgent care, inpatient, and emergency room visits.
Clinicians should use immunoassay screens and urine drug tests to determine compliance with chronic opioid therapy.
A report on current legislation and practice trends regarding opioids and how they are affecting cancer patients' ability to manage their pain.
Investigators the effectiveness of an intervention to reduce aberrant opioid-related behavior and use of opioids in patients with cancer receiving chronic opioid therapy.
The Rx Awareness campaign uses testimonials to educate the public, increase awareness about opioid abuse risks.
A significant variation in opioid prescribing practices was observed for each of 25 common elective procedures.
U.S. cases of opioid-related hospitalizations rose 75 percent for females versus 55 percent for males over a decade, researchers say
New safety issues are detected in almost one-third of drugs approved by the US FDA in the first 3 years after approval.
This study assessed whether the implementation of a patient educational program would improve patterns in the use, storage, and disposal of opioids among cancer outpatients.
What is the interaction between oral chemotherapy and GERD medicines?
Patient abuse of opioids costs the U.S. economy $78.5 billion a year, including the costs of health care, lost productivity, and treatment programs.
Nearly one-third of older patients with cancer are exposed to severe drug interactions and potentially inappropriate medications.
Patients with cancer experience higher risks for injuries — both unintentional and intentional — in the weeks before and after a diagnosis of cancer is made.
[Cancer Control] Two cases of Bordetella pertussis infection that led to pneumonia in patients with cancer are reviewed.
Health experts note that opioids are prescribed too often, possibly because of poor training, and U.S. medical schools are expanding training to address the issue.
Significant evidence indicates that gloves of health care workers contaminate hospital surfaces with bacteria.
A breakthrough technique in the manufacture of injectable drugs removed surfactants in an effort to reduce serious allergic reactions and other side effects, making injectable medicines safer.
Much of the risk related to long-acting opioids is tied to cardiovascular complications, not overdoses.
This fact sheet explains investigational drugs and the process by which cancer patients may obtain them.
Campaign urges health care professionals and patients and loved ones to keep hands clean.
A nurse-facilitated oral chemotherapy care model has improved delivery times, patient satisfaction, and co-pay support at a Connecticut cancer hospital.
A formal nursing practice was developed to promote patient safety and adherence with oral chemotherapy.
High-risk medications can increase falls in patients undergoing treatment for malignant hematology, but implementing risk-specific fall prevention strategies can ameliorate the effects of the drugs.
In the latest step to combat the epidemic of opioid abuse, U.S. officials urge generic drug makers to make changes to opioids.
Mainly supportive of guidelines, but concerns include a lack of evidence underlying some new recommendations.
Sign Up for Free e-newsletters
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Cervical Cancer Outcomes Comparable With Adjuvant Chemotherapy, Chemoradiotherapy
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|